August 6, 2025

The Trump administration has announced a sweeping rollback of federal investment in mRNA vaccine development, signaling a major shift in public health priorities with potentially dangerous consequences for the nation’s most vulnerable populations. Health and Human Services Secretary Robert F. Kennedy Jr. revealed that 22 federally funded contracts—totaling nearly $500 million—focused on developing mRNA-based vaccines are being terminated. These efforts, overseen by the Biomedical Advanced Research and Development Authority (BARDA), were key components of the federal government’s pandemic preparedness and vaccine innovation strategy. A Blow to Pandemic Preparedness mRNA technology proved to be a pivotal tool during the COVID-19 pandemic, enabling the rapid development of life-saving vaccines. Its adaptability allows scientists to quickly respond to emerging viral threats—an advantage critical for protecting Americans during future outbreaks. Shutting down these programs risks dismantling that progress and severely hampering the country’s readiness for the next public health emergency. BARDA’s collaborations with institutions